[1] [1] KINCAID J, SCHATZ H. Bilateral retinal arteritis with multiple aneurysmaldilatations［J］. Scientific Reports, 1983, 3(3): 171-178.

[2] [2] BAJGAI P, KATOCH D, DOGRA M R, et al. Idiopathic retinalvasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: Clinical perspectives［J］. Clinical Ophthalmology, 2017, 11: 1805-1817.

[3] [3] PICHI F, CIARDELLA A P. Imaging in the diagnosis and management of idiopathic retinalvasculitis, aneurysms, and neuroretinitis (IRVAN)［J］. International Ophthalmology Clinics, 2012, 52(4): 275-282.

[5] [5] SAMUEL M A, EQUI R A, CHANG T S, et al. Idiopathic retinitis,vasculitis, aneurysms, and neuroretinitis (IRVAN): New observations and a proposed staging system［J］. Ophthalmology, 2007, 114(8): 1526-1529.

[8] [8] YESHURUN I, RECILLAS-GISPERT C, NAVARRO-LOPEZ P, et al. Extensive dynamics in location, shape, and size of aneurysms in a patient with idiopathic retinalvasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome［J］. American Journal of Ophthalmology, 2003, 135(1): 118-120.

[9] [9] LIU X C, ZHANG M N, CHEN B, et al. A new perspective for analyzing clinical characteristics of idiopathic retinalvasculitis, aneurysms, and neuroretinitis syndrome［J］. International Ophthalmology, 2019, 39(7): 1475-1482.

[10] [10] KUMAWAT D, KUMAR V. Resolution of arterial aneurysms in idiopathic retinalvasculitis, aneurysms and neuroretinitis: A case report and review of literature［J］. International Ophthalmology, 2019, 39(5): 1155-1161.

[11] [11] KARAGIANNIS D, SOUMPLIS V, GEORGALAS I, et al.Ranibizumab for idiopathic retinal vasculitis, aneurysms, and neuroretinitis: favorable results［J］. European Journal of Ophthalmology, 2010, 20(4): 792-794.

[12] [12] TOMITA M, MATSUBARA T, YAMADA H, et al. Long term follow up in a case of successfully treated idiopathic retinalvasculitis, aneurysms, and neuroretinitis (IRVAN)［J］. The British Journal of Ophthalmology, 2004, 88(2): 302-303.

[13] [13] RODRGUEZ , CARPIO-ROSSO W, RODRGUEZ F J. Further observations on a bilateral IRVAN syndromecase［J］. International Ophthalmology, 2019, 39(5): 1179-1186.

[15] [15] CHANG T S, AYLWARD G W, DAVIS J L, et al. Idiopathic retinalvasculitis, aneurysms, and neuro-retinitis. Retinal Vasculitis Study［J］. Ophthalmology, 1995, 102(7): 1089-1097.

[16] [16] MASSICOTTE E, HASSANALY S, BLAIR M L, et al. Long-term outcomes in a series of idiopathic retinalvasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome［J］. Canadian Journal of Ophthalmology, 2018, 53(5): 435-440.